August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain

Time frame: 1 April 2023 - 31 March 2024


Overall research output

Count Share
Overall 122 13.49

Overall Count and Share for 'August Pi i Sunyer Biomedical Research Institute (IDIBAPS)' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 44 5.82
Chemistry 1 0.58
Health sciences 87 8.73
Physical sciences 2 0.12

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs.

Note: Hover over the donut graph to view the Share for each subject.

Institution benchmarking

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.


International vs domestic collaboration by Share

Type Percentage
International (1198 institutions) 59.1%
Domestic (210 institutions) 40.9%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with August Pi i Sunyer Biomedical Research Institute (IDIBAPS) by Share

Collaborating institutions


Top 5 international collaborators with August Pi i Sunyer Biomedical Research Institute (IDIBAPS) by Share

Collaborating institutions


Job finder

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

  • Advertisement

Latest supplement

Nature Index 2024 China

China's status at the summit of the Nature Index remains unrivalled as the gap between it and the United States grows. The key question is where Chinese research will go next. As the nation seeks international recognition for its scientific achievements, betting big on large-scale experiments, it is also carving its own path in publishing and partnerships. Time will tell how these strategies will shift the status quo of the global research landscape.

Nature Index 2024 China

Partner Institutions

August Pi i Sunyer Biomedical Research Institute (IDIBAPS) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Affiliated joint institutions and consortia